| 1. |
|
|
| 2. |
- Matar, Amal
(författare)
-
SIENNA D5.2 : An international code of conduct for data sharing in genomics
- 2021
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- As part of the SIENNA consortium proposals (WP5), the deliverable proposes an international code of conduct for data sharing in genomics. It builds on results of D 2.3: Survey of REC approaches and codes for genomics, D2.4: Ethical analysis of human genetics and genomics and D5.6: Recommendations for the enhancement of the existing legal frameworks for genomics, human enhancement, and AI and robotics.To draft the proposed code of conduct, we adopted a mix of methods involving a literature review, synthesis of pertinent existing codes of conduct, a workshop of an expert panel and soliciting feedback from SIENNA stakeholders.The deliverable addresses specific concerns and gaps as identified via literature namely; identifiability, broad consent, portability accessibility and return of results, compelled disclosure and lastly withdrawal of consent. Furthermore, we propose mitigation measures as recommended by experts and stakeholders and through synthesis of relevant past codes. The results have been discussed in the light of GDPR which is the most relevant legal framework within the EU.
|
|
| 3. |
- Brey, Philip, et al.
(författare)
-
SIENNA D6.3 : Methods for translating ethical analysis into instruments for the ethical development and deployment of emerging technologies
- 2021
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- In this SIENNA deliverable we present five general methods for translating ethical analysis into frameworks and methods for the ethical guidance of new emerging technologies. These are:a multistakeholder, coevolutionary strategy for ethically responsible development, deployment and use of new technology,a step-by-step method for the development of ethics guidelines and ways in which guidelines can be operationalized,a general approach for Ethics by Design, that works for all technology fields,suggestions for ethics and human rights projects on new and emerging technologies forengaging with policy-maker, and finallya method on how research ethics committees can support ethics in new emerging technology research.
|
|
| 4. |
- Svahn, Ola, 1970-, et al.
(författare)
-
Interkalibrerad läkemedelsanalys 2017 : ett samarbetsprojekt för ökad analyskvalité
- 2017
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- Läkemedelsverket gav i september 2015 ut en rapport med titeln ”Miljöindikatorer inom ramen för nationella läkemedelsstrategin (NLS)”. Rapporten indikerar bland annat stora kvalitetsbrister i tidigare utförda analyser av läkemedel i miljön under åren 2002-2013, men betonar också vikten av att samordna framtida nationella läkemedelsanalyser för att bättre använda våra offentliga resurser. I rapporten skriver man följande: ”Allra högst prioriterad ansåg arbetsgruppen att indikatorn ”mäta halter av läkemedelssubstanser i miljö” vara. Detta beroende på att det utöver att det är av stor vikt att följa utvecklingen av läkemedelsrester i miljön över tid för att utvärdera effekten av genomförda insatser, så ansåg arbetsgruppen att det finns stora möjligheter att optimera användningen av de offentliga resurserna genom en bättre samordning av mätningar i miljön. Många mätningar har gjorts historiskt av olika offentliga aktörer utan någon samordning.” Mot bakgrund av detta, och som svar på ett nationellt behov, åtog sig Högskolan Kristianstad (HKR) genom Ola Svahn och Erland Björklund, båda verksamma vid MoLab, Krinova Incubator and Science Park i Kristianstad, att leda denna interkalibreringsstudie för läkemedelsanalys i miljö-vattenprover av olika typ. Arbetet har skett på uppdrag av Havs- och Vattenmyndigheten som finansierat arbetet via bidrag ur havs- och vattenmiljöanslaget och i samarbete med fyra andra analyslaboratorier vid Umeå Universitet (UU), Sveriges Lantbruksuniversitet Uppsala (SLU), Svenska miljöinstitutet Stockholm (IVL) samt Aarhus Universitet Danmark (AU). Total deltog därmed 5 laboratorier, alla med tidigare erfarenhet av läkemedelsanalys i miljöprover.
|
|
| 5. |
|
|
| 6. |
- Mellqvist, Johan, 1965, et al.
(författare)
-
Fixed remote surveillance of fuel sulfur content in ships from fixed sites in the Göteborg ship channel and Öresund bridge
- 2017
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- In 2015 new rules from the IMO and legislation from EU (Sulfur directive) and the US requires ships to run with maximum fuel sulfur content (FSC) of 0.1 % m/m in northern European and North American waters. In order to promote a level playing field within the shipping sector, there is a need for measurement systems that can make effective compliance control and this is the main objective of the CompMon project, funded through the European CEF program (Connecting Europe Facility). As part of this project, an automatic sniffer sensor system has been applied in the Göteborg ship channel at the Älvsborg island during 3 years (2014- 2016) and at the Öresund Bridge during two months at the end of 2016. The typical distances from the ships here varied between 500 -1000 m. The sniffer system is based on several extractive instruments measuring concentrations of SO2 and CO2 and others species, such as NOx, in the ship emission plumes that drift over the measurement station. In addition to fixed stations, the system can also be used from mobile platforms such as harbor patrol vessels and aircraft. From the data above, together with information about the ships from AIS (Automatic Identification System) and wind data, the FSC is automatically calculated and the ship is identi- fied. This is done using software developed as part of this project (Single Emitter identification Tool). The measurement precision (1σ) of the sniffer system is approx. 0.04 % m/m for ships using a FSC of 0.1 % m/m. The sniffer system also has a negative bias in the measured FSC, varying between 0.04 % to 0.08 % m/m and this is accounted for when calculating the threshold for non-compliance. Based on the above, it is possible to identify ships with FSC above 0.18 % m/m with 95% confidence limit, if the bias is corrected for statistically. For the measurements at the Älvsborg island site in 2014 and 2015, the corresponding limit is higher, 0.29 % m/m, due to a measurement artifact that was eliminated in 2016. On board measurements in 2015 and 2016 by the Swedish port state control authority shows that most non-compliant ships had FSCs be- tween 0.1 % to 0.2 % m/m when controlled at berth and this is generally below the 95% confidence limit threshold of the sniffer. Therefore many non-compliant ships will not be detected when using the sniffer close to harbors and a more precise sensor is therefore preferred. The measurements at the Älvsborg island were carried out during a time period when the allowed FSC limit changed significantly. The data for 2014, corresponding to more than 4000 measurements of 500 individual ships, shows that 99 % of the ships were using compliant fuel below the FSC limit of 1 % m/m. In 2015 the FSC limit changed to 0.1 % m/m. The measurements in 2015 and 2016, corresponding to the same amount of ships as in 2014, showed that 91.5 % and 98 %, respectively, were using compliant fuel with respect to FSC. The lower compliance rate in 2015 compared to 2016 is potentially influenced by measurement artifacts that were later eliminated in 2016. At the Öresund Bridge. 58 ships were measured as part of the CompMon pro- ject. The measurements continued another month with support from the interreg project Envisum, with anoth- er 62 ships measured. The compliance level at the Öresund Bridge corresponds to 98 %. This is actually com- parable to the corresponding measurements elsewhere and at the Älvsborg island site during the same time period.
|
|
| 7. |
|
|
| 8. |
- Ryan, Amy L, et al.
(författare)
-
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases 2017 : An Official American Thoracic Society Workshop Report
- 2019. - 4
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- The University of Vermont Larner College of Medicine, in collaboration with the National Heart, Lung, and Blood Institute (NHLBI), the Alpha-1 Foundation, the American Thoracic Society, the Cystic Fibrosis Foundation, the European Respiratory Society, the International Society for Cell & Gene Therapy, and the Pulmonary Fibrosis Foundation, convened a workshop titled "Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases" from July 24 through 27, 2017, at the University of Vermont, Burlington, Vermont. The conference objectives were to review and discuss current understanding of the following topics: 1) stem and progenitor cell biology and the role that they play in endogenous repair or as cell therapies after lung injury, 2) the emerging role of extracellular vesicles as potential therapies, 3) ex vivo bioengineering of lung and airway tissue, and 4) progress in induced pluripotent stem cell protocols for deriving lung cell types and applications in disease modeling. All of these topics are research areas in which significant and exciting progress has been made over the past few years. In addition, issues surrounding the ethics and regulation of cell therapies worldwide were discussed, with a special emphasis on combating the growing problem of unproven cell interventions being administered to patients with lung diseases. Finally, future research directions were discussed, and opportunities for both basic and translational research were identified.
|
|
| 9. |
|
|
| 10. |
|
|
